99 related articles for article (PubMed ID: 10806670)
1. [The effect of estrogen replacement therapy on plasma nitric oxide levels in postmenopausal women].
Ye Y; Dai S; Zhang S
Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):340-1. PubMed ID: 10806670
[TBL] [Abstract][Full Text] [Related]
2. [Changes of nitric oxide and endothelin plasma levels and effects of hormone replacement therapy in postmenopausal women].
Lai A; Zhang J; Ding L
Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):222-4. PubMed ID: 11776165
[TBL] [Abstract][Full Text] [Related]
3. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
[TBL] [Abstract][Full Text] [Related]
4. A comparison of effects of sequential transdermal administration versus oral administration of estradiol plus norethisterone acetate on serum NO levels in postmenopausal women.
Kurtay G; Ozmen B; Erguder I
Maturitas; 2006 Jan; 53(1):32-8. PubMed ID: 16325022
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17 beta-estradiol valerate and cyproterone acetate or medroxyprogesterone acetate.
Imthurn B; Rosselli M; Jaeger AW; Keller PJ; Dubey RK
J Clin Endocrinol Metab; 1997 Feb; 82(2):388-94. PubMed ID: 9024224
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of oral and transdermal hormone replacement therapy on plasma homocysteine levels.
Chiantera V; Sarti CD; Fornaro F; Farzati A; De Franciscis P; Sepe E; Borrelli AL; Colacurci N
Menopause; 2003; 10(4):286-91. PubMed ID: 12851511
[TBL] [Abstract][Full Text] [Related]
7. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
[TBL] [Abstract][Full Text] [Related]
8. [Effect of hormone replacement therapy on coagulation function in postmenopausal women].
Ye Y; Gao P; Guo X
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):285-7. PubMed ID: 11775909
[TBL] [Abstract][Full Text] [Related]
9. Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thrombosis: a randomized, placebo-controlled study in postmenopausal women.
Post MS; Christella M; Thomassen LG; van der Mooren MJ; van Baal WM; Rosing J; Kenemans P; Stehouwer CD
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1116-21. PubMed ID: 12730085
[TBL] [Abstract][Full Text] [Related]
10. Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy.
Im JA; Lee JW; Lee HR; Lee DC
Maturitas; 2006 Apr; 54(1):65-71. PubMed ID: 16198517
[TBL] [Abstract][Full Text] [Related]
11. Oral estrogen replacement therapy increases forearm reactive hyperemia accompanied by increases in serum levels of nitric oxide in postmenopausal women.
Sanada M; Higashi Y; Nakagawa K; Sasaki S; Kodama I; Sakashita T; Tsuda M; Ohama K
Gynecol Endocrinol; 2001 Apr; 15(2):150-7. PubMed ID: 11379012
[TBL] [Abstract][Full Text] [Related]
12. Plasma orexin-A levels in postmenopausal women: possible interaction with estrogen and correlation with cardiovascular risk status.
El-Sedeek MSh; Korish AA; Deef MM
BJOG; 2010 Mar; 117(4):488-92. PubMed ID: 20105164
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide in postmenopausal women taking three different HRT regimens.
Kesim MD; Aydin Y; Erdemir M; Atis A
Maturitas; 2005 Jan; 50(1):52-7. PubMed ID: 15590214
[TBL] [Abstract][Full Text] [Related]
14. The effect of estrogen replacement therapy on plasma serotonin and catecholamines of postmenopausal women.
Blum I; Vered Y; Lifshitz A; Harel D; Blum M; Nordenberg Y; Harsat A; Sulkes J; Gabbay U; Graff E
Isr J Med Sci; 1996 Dec; 32(12):1158-62. PubMed ID: 9007144
[TBL] [Abstract][Full Text] [Related]
15. Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women.
Kunnari A; Santaniemi M; Jokela M; Karjalainen AH; Heikkinen J; Ukkola O; Kesäniemi YA
Metabolism; 2008 Nov; 57(11):1509-15. PubMed ID: 18940387
[TBL] [Abstract][Full Text] [Related]
16. Short-term estrogen replacement therapy reduces platelet marker levels in Malaysian postmenopausal women.
Sheikh SA; Roshan TM; Khattak MN; Baig AA; Noor SJ; Hassan R; Zaki NM
Menopause Int; 2011 Mar; 17(1):6-10. PubMed ID: 21427417
[TBL] [Abstract][Full Text] [Related]
17. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
Rachoń D; Suchecka-Rachoń K; Hak Ł; Myśliwska J
Menopause; 2006; 13(5):840-5. PubMed ID: 16894332
[TBL] [Abstract][Full Text] [Related]
18. Effects of estrogen replacement therapy on plasma levels of nitric oxide in postmenopausal women.
Cicinelli E; Ignarro LJ; Matteo MG; Galantino P; Schonauer LM; Falco N
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):334-9. PubMed ID: 9988796
[TBL] [Abstract][Full Text] [Related]
19. The effect of acute ethanol ingestion on estrogen levels in postmenopausal women using transdermal estradiol.
Ginsburg ES; Walsh BW; Gao X; Gleason RE; Feltmate C; Barbieri RL
J Soc Gynecol Investig; 1995; 2(1):26-9. PubMed ID: 9420845
[TBL] [Abstract][Full Text] [Related]
20. Comparison of estrogen and androgen levels after oral estrogen replacement therapy.
Slater CC; Zhang C; Hodis HN; Mack WJ; Boostanfar R; Shoupe D; Paulson RJ; Stanczyk FZ
J Reprod Med; 2001 Dec; 46(12):1052-6. PubMed ID: 11789085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
